[Elsevier] Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer

Humah Post time 2026-10-20 07:53:55 | Show all posts |Read mode
This post will be closed automatically in 2026-10-23 07:53
Reward10points

journalㄩAnnals of Oncology

AuthorsㄩN.C. Turner; C. Swift; B. Jenkins; L. Kilburn; M. Coakley; M. Beaney; L. Fox; K. Goddard; I. Garcia-Murillas; P. Proszek; P. Hall; C. Harper-Wynne; T. Hickish; S. Kernaghan; I.R. Macpherson; A.F.C. Okines; C. Palmieri; S. Perry; K. Randle; C. Snowdon; H. Stobart; A.M. Wardley; D. Wheatley; S. Waters; M.C. Winter; M. Hubank; S.D. Allen; J.M. Bliss;  S. Chan; A. Armstrong; F. Raja; P. Schmid; A. Tutt; R. Roux; S. Cleator

Published dateㄩ2023-2-

DOIㄩ10.1016/j.annonc.2022.11.005

PDF linkㄩhttps://www.sciencedirect.com/sc ... 923753422047354/pdf

Article linkㄩhttps://doi.org/10.1016/j.annonc.2022.11.005

Article SourceㄩElsevier BV﹝


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
efraim Post time 2026-10-20 07:53:56 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    1236


Daily Top Contributors

Return to the list